The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma

Author(s):

Luned M. Badder, James A. Davies, Valerie S. Meniel, Mahulena Marušková, Beatriz Salvador-Barbero, Rebecca J. Bayliss, Toby J. Phesse, Catherine Hogan, Alan L. Parker

Details:

British Journal of Cancer, Volume 131, Issue 10, 2024-11-30

Article Link: Click here

Affiliations:

• Cardiff University School of Medicine
• College of Biomedical and Life Sciences
• The Peter Doherty Institute for Infection and Immunity